HOME > TOP STORIES
TOP STORIES
-
BUSINESS Harvoni No. 1 Drug in Japan in 2016 with Sales of 296 Billion Yen, More than Any Other Drug Over Past 10 Years: IMS Japan
February 10, 2017
-
REGULATORY Bill Payers, Doctors in Skirmish over Drug Price Survey for Gap-Year Revisions: Chuikyo
February 9, 2017
-
REGULATORY Chuikyo OKs Optimal Use Guidelines for Opdivo and Keytruda, Due Out Feb. 14
February 9, 2017
-
REGULATORY Keytruda Gets Same Daily Price as Opdivo; Chuikyo OKs Batch of Drugs for Feb. 15 Listing
February 8, 2017
-
INTERVIEW CEO Weber Says Takeda’s Ongoing Transformation “Irreversible”: Full Interview
February 8, 2017
-
TRENDS Montelukast AG Achieves Rapid Market Penetration, Enjoys Stronger Start than Candesartan AG
February 7, 2017
-
BUSINESS Takeda Wants to Be Global GI Leader in 2025, Not in Acquisition Frenzy Mode: CEO
February 3, 2017
-
ORGANIZATION US Exclusion from Foreign Price Adjustment Should Be Carefully Considered: PhRMA Japan Chief
February 2, 2017
-
REGULATORY MHLW Pins Down Distribution Routes for Harvoni Counterfeits; Composition of Fake Pills Identified
February 1, 2017
-
BUSINESS Daiichi Sankyo Taps EVP Manabe as Next President
February 1, 2017
-
BUSINESS Major Products Face Impending Listing of Generics, though Patents Remain for Some
February 1, 2017
-
REGULATORY MHLW, Pharma Industry Officials Agree on Conditional Early Approval System
January 31, 2017
-
COMMENTARY Top-Notch Talents Needed for Pharma’s Lobbying Activities; Stay Current with Policymaking Moves
January 30, 2017
-
BUSINESS Daiichi Sankyo Espha to Launch Micardis AG, Will Actively Handle Competitors’ Products
January 27, 2017
-
REGULATORY MHLW Warns Against Purchasing Harvoni in Unpackaged Bottles
January 26, 2017
-
REGULATORY (Update) Chuikyo Agrees to Shed US Price from Foreign Price Adjustment Rule
January 25, 2017
-
REGULATORY Counterfeit Harvoni Found in Tokyo Too, Route Identified for a Nara Bottle
January 24, 2017
-
BUSINESS Ferring Speeding Up R&D in Core Sectors, Positive on Licensing and M&A: Japan CEO
January 23, 2017
-
ORGANIZATION JGA Head Frets Majority of Products Subject to Gap-Year Revisions Will Be Generics
January 20, 2017
-
BUSINESS Gilead Japan to Switch Sovaldi, Harvoni Bottles to Blister Packs
January 19, 2017
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
